Rankings
▼
Calendar
VIR Q4 2025 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
VIR
Vir Biotechnology, Inc.
$1B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$64M
+417.8% YoY
Gross Profit
$431M
672.1% margin
Operating Income
-$37M
-57.1% margin
Net Income
-$43M
-67.0% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+26595.8%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$21M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$238M
Stockholders' Equity
$765M
Cash & Equivalents
$234M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$12M
+417.8%
Gross Profit
$431M
-$76M
+663.5%
Operating Income
-$37M
-$117M
+68.7%
Net Income
-$43M
-$105M
+59.0%
Revenue Segments
Grant
$310,000
100%
Geographic Segments
Non-US
$61M
99%
UNITED STATES
$310,000
1%
← FY 2025
All Quarters